Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesEverolimus Represents an Advance in Immunosuppression for Patients Who Have Developed Cancer After Renal Transplantation
Transplantation Proceedings, 09/11/09
Gonzalez E et al. – The results suggested that immunosuppression with everolimus combined with low doses of CNIs or in single–drug therapy is safe immunosuppression for patients who develop posttransplant malignant diseases.
Related Articles
Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09
Relevance Score: 94%
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09
Relevance Score: 94%
Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 94%
Factors influencing liver transplant length of stay at two large-volume transplant centers
Liver Transplantation, 11/03/09
Relevance Score: 93%
Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 93%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence and predictors of recurrent IgA nephropathy following renal transplantation
Irish Journal of Medical Science, 12/18/09
Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09
Late Acute Kidney Transplant Rejection: Clinicopathological Correlates and Response to Corticosteroid Therapy
Transplantation Proceedings, 12/18/09
Article Search
Sponsor